Somatropin
Humatrope is a prescription injectable medication containing somatropin, a synthetic form of human growth hormone, manufactured by Eli Lilly and Company. It comes in various strengths (e.g., 2mg, 5mg, 6mg, 12mg, 24mg vials) and is administered intramuscularly or subcutaneously to treat growth hormone deficiencies. Some formulations are discontinued. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Humatrope is a prescription injectable medication containing somatropin, a synthetic form of human growth hormone, manufactured by Eli Lilly and Company. It comes in various strengths (e.g., 2mg, 5mg, 6mg, 12mg, 24mg vials) and is administered intramuscularly or subcutaneously to treat growth hormone deficiencies. Some formulations are discontinued. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Somatropin",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Somatropin — ANDA 019774 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019774"
}
]
|
| identifier | ANDA019774 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-manufacturers",
"fda",
"health-care",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Somatropin |
